AI in Resource-Poor Healthcare Settings: A Beacon of Hope

By Sumona Bose

December 12, 2023

Artificial Intelligence: A Game Changer in Healthcare

The transformative power of Artificial Intelligence (AI) in healthcare is undeniable. Primarily, AI, a facet of computer science that replicates intelligent behaviour, comes in two forms. The first, artificial general intelligence, emulates the human mind. The second, artificial narrow intelligence, excels at a single task. Most AI applications in healthcare belong to the latter category.

AI can be utilised in numerous ways within healthcare. Expert systems, for example, can solve specific problems with a high level of competence. Machine learning, an AI subfield, automates data analysis by detecting patterns. Natural language processing (NLP) bridges the divide between human and computer languages, enabling AI to comprehend text. Automated planning and scheduling organise activities to achieve a goal, while image and signal processing handle data from images and signals.

AI’s Promise in Resource-Poor Settings

AI has already proven beneficial in resource-poor settings. For instance, expert systems have been used to forecast cholera outbreaks in South Africa and birth asphyxia in Brazil. Machine learning has predicted dengue fever transmission in Manila, while NLP has been used for disease surveillance and outbreak predictions. AI planning has enhanced primary healthcare services, and signal processing has predicted birth asphyxia using a mobile phone in Nigeria.

However, implementing AI in resource-poor settings is not without challenges. These include the need for high-quality datasets, robust electronic health record systems, and substantial IT infrastructure. There are also ethical considerations around privacy, confidentiality, data security, informed consent, and data ownership. Cultural biases can also be reflected in data and algorithms, potentially exacerbating inequities.

AI’s Challenges and Insights

Despite these challenges, AI holds enormous potential for improving public health outcomes in low-income countries. The widespread use of smartphones, combined with growing investments in supporting technologies like mobile health, electronic medical records, and cloud computing, provide ample opportunities for AI applications. However, transitioning from pilot to scale will require addressing several issues, including legal and ethical questions, understanding local contexts, and developing a robust research agenda.

In conclusion, AI has the potential to significantly improve healthcare in resource-poor settings. However, it’s crucial that we navigate the challenges and ethical considerations carefully to ensure that this promising technology can truly benefit those who need it most.

Reference url

Recent Posts

lenacapavir HIV PrEP access
    

Global Health Partnerships Unite to Expand Access to Lenacapavir for HIV Prevention

💉 How can we ensure equitable access to HIV prevention methods like lenacapavir?

A recent initiative from the Global Fund, supported by key global health organizations, aims to provide affordable access to this new HIV pre-exposure prophylaxis medication.

With a goal to reach 2 million individuals over three years, this coordinated effort seeks to drastically cut HIV infections and align with our commitment to ending AIDS by 2030.

Explore the details of this impactful collaboration and how it could transform HIV prevention.

#SyenzaNews #globalhealth #HealthcareInnovation #MarketAccess

antimicrobial resistance africa
     

Africa’s Health Crisis: Antimicrobial Resistance and Mpox Outbreak

🌍 Are we prepared to tackle the hidden pandemic of antimicrobial resistance (AMR) in Africa?

With AMR rapidly becoming a dominant health crisis, it’s critical to understand its impact on our healthcare systems and most vulnerable populations.

The Africa CDC highlights the urgent need for substantial investment and coordinated responses to combat this escalating threat, alongside the ongoing Mpox outbreak.

Discover the pressing challenges and potential solutions in our latest article.

#SyenzaNews #GlobalHealth #HealthcareInnovation #AntimicrobialResistance #PublicHealth

BioSapien cancer drug delivery
    

BioSapien Innovative Cancer Drug Delivery Solutions

🌟 How is innovation in drug delivery shaping the future of cancer treatment? 🌟

Discover how UAE-based BioSapien is transforming the healthcare landscape with the MediChip™ platform, securing $5.5 million in pre-Series A funding to enhance cancer care.

This innovative solution promises to minimise side effects and improve treatment outcomes for patients, fully embracing the potential of biotechnology in the fight against cancer.

Read more about BioSapien’s journey and its impact on global health!

#SyenzaNews #biotechnology #oncology #innovation #HealthTech

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

© 2024 Syenza™. All rights reserved.